NeoImmuneTech, Inc. (KOSDAQ: 950220)
1,624.00
-121.00 (-6.93%)
Sep 10, 2024, 9:00 AM KST
NeoImmuneTech Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Cash & Equivalents | 52,402 | 68,739 | 115,630 | 154,250 | 71,217 | 102,149 | Upgrade
|
Short-Term Investments | 2,095 | 333.38 | 1,445 | 220.29 | 0.9 | 5,890 | Upgrade
|
Cash & Short-Term Investments | 54,497 | 69,072 | 117,075 | 154,471 | 71,218 | 108,039 | Upgrade
|
Cash Growth | -40.25% | -41.00% | -24.21% | 116.90% | -34.08% | 130.50% | Upgrade
|
Prepaid Expenses | - | 3,185 | 895.8 | - | - | - | Upgrade
|
Other Current Assets | 5,157 | - | -0 | 12,252 | 9,414 | 1,654 | Upgrade
|
Total Current Assets | 59,654 | 72,257 | 117,971 | 166,722 | 80,632 | 109,692 | Upgrade
|
Property, Plant & Equipment | 5,622 | 7,749 | 9,397 | 9,056 | 4,058 | 3,082 | Upgrade
|
Other Intangible Assets | 6,376 | 6,168 | 6,554 | 6,591 | 6,471 | 7,335 | Upgrade
|
Other Long-Term Assets | 967.94 | 4,338 | 5,944 | 4,659 | 4,484 | 1,159 | Upgrade
|
Total Assets | 72,620 | 90,511 | 139,865 | 187,027 | 95,645 | 121,268 | Upgrade
|
Accrued Expenses | 9,522 | 8,764 | 12,945 | 17,426 | 7,493 | 1,319 | Upgrade
|
Current Portion of Leases | 1,062 | 1,353 | 1,279 | 1,284 | 545.01 | 441.48 | Upgrade
|
Current Income Taxes Payable | - | 58.51 | 92.49 | 59.33 | 21.63 | - | Upgrade
|
Other Current Liabilities | 1,660 | 2,710 | 2,080 | 1,642 | 938.61 | 1,247 | Upgrade
|
Total Current Liabilities | 12,244 | 12,886 | 16,397 | 20,411 | 8,998 | 3,007 | Upgrade
|
Long-Term Leases | 1,385 | 2,555 | 3,572 | 4,511 | 2,360 | 2,375 | Upgrade
|
Other Long-Term Liabilities | 63.46 | 62.24 | 64.34 | 63.09 | 0 | 0 | Upgrade
|
Total Liabilities | 13,795 | 15,655 | 20,176 | 24,985 | 11,418 | 5,382 | Upgrade
|
Common Stock | 2.75 | 2.55 | 2.51 | 2.34 | 1.8 | 1.91 | Upgrade
|
Additional Paid-In Capital | 318,664 | 295,772 | 290,644 | 271,282 | 142,448 | 151,159 | Upgrade
|
Retained Earnings | -287,907 | -246,517 | -190,424 | -122,781 | -62,771 | -36,913 | Upgrade
|
Comprensive Income & Other | 28,066 | 25,599 | 19,466 | 13,539 | 4,547 | 1,638 | Upgrade
|
Shareholders' Equity | 58,825 | 74,856 | 119,689 | 162,042 | 84,227 | 115,886 | Upgrade
|
Total Liabilities & Equity | 72,620 | 90,511 | 139,865 | 187,027 | 95,645 | 121,268 | Upgrade
|
Total Debt | 2,447 | 3,908 | 4,851 | 5,795 | 2,905 | 2,816 | Upgrade
|
Net Cash (Debt) | 52,050 | 65,164 | 112,224 | 148,676 | 68,312 | 105,223 | Upgrade
|
Net Cash Growth | -40.00% | -41.93% | -24.52% | 117.64% | -35.08% | 124.49% | Upgrade
|
Net Cash Per Share | 526.89 | 659.23 | 1136.26 | 1560.75 | 826.59 | 1292.31 | Upgrade
|
Filing Date Shares Outstanding | 100.26 | 494.34 | 494.14 | 492.91 | 413.63 | 411.63 | Upgrade
|
Total Common Shares Outstanding | 100.26 | 494.34 | 494.14 | 492.91 | 413.63 | 411.63 | Upgrade
|
Working Capital | 47,410 | 59,371 | 101,574 | 146,311 | 71,633 | 106,685 | Upgrade
|
Book Value Per Share | 586.74 | 151.43 | 242.22 | 328.75 | 203.63 | 281.53 | Upgrade
|
Tangible Book Value | 52,449 | 68,689 | 113,136 | 155,452 | 77,756 | 108,551 | Upgrade
|
Tangible Book Value Per Share | 523.15 | 138.95 | 228.96 | 315.38 | 187.99 | 263.71 | Upgrade
|
Machinery | 6,206 | 5,727 | 4,864 | 3,027 | 1,307 | 432.53 | Upgrade
|
Construction In Progress | - | - | - | 764.66 | 46.55 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.